DE69133172D1 - Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum - Google Patents

Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum

Info

Publication number
DE69133172D1
DE69133172D1 DE69133172T DE69133172T DE69133172D1 DE 69133172 D1 DE69133172 D1 DE 69133172D1 DE 69133172 T DE69133172 T DE 69133172T DE 69133172 T DE69133172 T DE 69133172T DE 69133172 D1 DE69133172 D1 DE 69133172D1
Authority
DE
Germany
Prior art keywords
necrophorum
treat liver
necrosis caused
liver necrosis
bacterin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69133172T
Other languages
English (en)
Other versions
DE69133172T2 (de
Inventor
John N Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Publication of DE69133172D1 publication Critical patent/DE69133172D1/de
Application granted granted Critical
Publication of DE69133172T2 publication Critical patent/DE69133172T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/114—Fusobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69133172T 1990-06-07 1991-05-25 Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum Expired - Fee Related DE69133172T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53489490A 1990-06-07 1990-06-07

Publications (2)

Publication Number Publication Date
DE69133172D1 true DE69133172D1 (de) 2003-01-23
DE69133172T2 DE69133172T2 (de) 2003-04-30

Family

ID=24131961

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69133172T Expired - Fee Related DE69133172T2 (de) 1990-06-07 1991-05-25 Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum
DE69116606T Expired - Fee Related DE69116606T2 (de) 1990-06-07 1991-05-25 Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69116606T Expired - Fee Related DE69116606T2 (de) 1990-06-07 1991-05-25 Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung

Country Status (8)

Country Link
US (1) US6132709A (de)
EP (2) EP0674905B1 (de)
AU (1) AU644440B2 (de)
CA (1) CA2043932C (de)
DE (2) DE69133172T2 (de)
ES (2) ES2084057T3 (de)
IE (1) IE72181B1 (de)
NZ (1) NZ238378A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455034A (en) * 1992-06-26 1995-10-03 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
EP0648260B1 (de) * 1992-06-26 2000-09-27 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vakzin
AU713257B2 (en) * 1995-06-07 1999-11-25 Kansas State University Research Foundation Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep
US5861162A (en) * 1995-06-07 1999-01-19 Kansas State University Research Foundation Multivalent inocula for lessening incidence of liver abscesses in cattle
US6632439B2 (en) 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
EP2240570B1 (de) 2008-01-18 2013-12-11 Werner Lubitz Verfahren zur herstellung von bakterienghost (bg) durch endinaktivierung mit betapropiolactone (blp)
CN102648003B (zh) 2009-10-09 2016-01-13 儿童医疗中心有限公司 选择性裂解的全细胞疫苗
ES2718491T3 (es) * 2012-11-29 2019-07-02 Univ Cornell Vacuna para enfermedad intrauterina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA984293A (en) * 1971-08-20 1976-02-24 Richard W. Moore Medium and method for growth of superiorly antigenic equine infectious anemia virus and production of immunizing vaccine therefrom
FR2174745A1 (en) * 1972-03-09 1973-10-19 Inst Elevage Med Vet Mixed veterinary vaccine - active against symptomatic and bacterial anthrax
US4061751A (en) * 1976-07-22 1977-12-06 American Cyanamid Company 6-Substituted 3-nitroimidazo[1,2-b]pyridazine for the control of foot rot and liver lesions in ruminant animals
US4203968A (en) * 1978-08-18 1980-05-20 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
NZ226332A (en) * 1987-09-28 1991-10-25 Beecham Inc Vaccine comprising transmissible gastroenteritis virus of swine for preventing canine coronavirus infection in dogs and process for preparation thereof

Also Published As

Publication number Publication date
EP0460480B1 (de) 1996-01-24
DE69133172T2 (de) 2003-04-30
CA2043932A1 (en) 1991-12-08
EP0674905A2 (de) 1995-10-04
EP0674905B1 (de) 2002-12-11
ES2084057T3 (es) 1996-05-01
EP0674905A3 (de) 1995-12-06
EP0460480A2 (de) 1991-12-11
CA2043932C (en) 2006-09-12
AU644440B2 (en) 1993-12-09
US6132709A (en) 2000-10-17
DE69116606D1 (de) 1996-03-07
ES2186694T3 (es) 2003-05-16
IE911940A1 (en) 1991-12-18
NZ238378A (en) 1992-12-23
AU7817791A (en) 1991-12-12
EP0460480A3 (en) 1992-04-01
DE69116606T2 (de) 1996-05-30
IE72181B1 (en) 1997-03-26

Similar Documents

Publication Publication Date Title
DE3674308D1 (de) Biozide zusammensetzungund verfahren zur behandlung von wasser.
DE3680130D1 (de) Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung.
DE68907909D1 (de) Praeparat zur behandlung von erektionsstoerungen.
ATE122205T1 (de) Fungizide zusammensetzung zur behandlung von saatgut.
DE69105046D1 (de) Verfahren zur Herstellung von Dekabromdiphenylalkan.
DE69107387D1 (de) Verfahren zur Herstellung von halberstarrten Metallzusammensetzungen.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
IT7925699A0 (it) Composizioni fotografiche di sbianca, e metodi per trattamento fotografico.
DE3481277D1 (de) Vorrichtung zur behandlung von gas-fluessigkeitsgemischen.
DE69133172D1 (de) Bacterin zur Behandlung von Lebernekrose verursacht durch F. Necrophorum
DE59106640D1 (de) Verfahren zur Herstellung von 1,3-Diketonen.
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
DE59103046D1 (de) Verfahren zur Herstellung von Alkylglycosiden und Alkylpolyglycosiden.
DE69013482D1 (de) Verfahren zur Herstellung von Organohalosilanen.
DE59102357D1 (de) Verfahren zur Herstellung von Diphenylaminen.
DE68903208D1 (de) Verfahren zur thermischen behandlung von laktoferrin.
DE3578135D1 (de) Behandlung eines ultrafiltrats durch elektrodialyse.
DE59402601D1 (de) Verfahren zur Herstellung von in alpha-Stellung durch einen Alkylrest substituierten Aldehyden
DE59101444D1 (de) Verfahren zur Herstellung von p-Amino-phenolen.
DE69108044D1 (de) Verfahren zur verbesserung der fliessencharakteristik von kristallinem ibuprofen.
IT7926896A0 (it) Perfezionamento nelle camere per il trattamento di pezzi.
DE59006697D1 (de) Verfahren zur Herstellung von 2-Chlor-5-methyl-pyridin.
DE59103772D1 (de) Verfahren zur Herstellung von Acylbenzolen.
DE69014580D1 (de) Verfahren zur Herstellung von Cyclopentadienyl-mangan-tricarbonyl-verbindungen.
DE3582224D1 (de) Durch niedrigwaermequelle angetriebene waermepumpe.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee